The project's main goal is to collect baseline clinical and procedural data as well as to assess clinical outcomes for all patients undergoing ECMO or Impella implantation at all included sites. All patients undergoing ECMO and/or IMPELLA implantation will be prospectively registered. Device use is according to the decision of the treating physician and independent of this registry.
This prospective data collection is made up of an all-comers design, including all eligible consecutive patients receiving an Impella (2.5, 5, CP, or RP) or VA-ECMO device via femoral access who gave their consent (or, if not possible, their relative). The project's main goal is to collect baseline clinical and procedural data as well as to assess clinical outcomes for all patients undergoing ECMO or Impella implantation at all included sites. All patients undergoing ECMO and/or IMPELLA implantation will be prospectively registered. Device use is according to the decision of the treating physician and independent of this registry.
Study Type
OBSERVATIONAL
Enrollment
1,500
Universitätsspital Basel
Basel, Switzerland
RECRUITINGInsel Gruppe AG, Inselspital Bern
Bern, Switzerland
RECRUITINGLuzerner Kantonsspital
Lucerne, Switzerland
RECRUITINGNumber of deceased participants at 1 month after cardiogenic shock
All-cause mortality at 30 days
Time frame: 30 days
Statistical and medical analysis of major adverse cardiac and cerebrovascular events (MACCE) reported by participants
Major adverse cardiac and cerebrovascular events (MACCE)
Time frame: 6 months
Statistical and medical analysis of vascular complications (VARC) reported by participants
Vascular complications (VARC)
Time frame: 6 months
Statistical and medical analysis of vascular surgery needed by participants
Need for vascular surgery
Time frame: 6 months
Statistical and medical analysis of bleeding complications (minor, major) reported by participants
Bleeding complications (minor, major)
Time frame: 6 months
Implantation time of MCS-device
Implantation time of MCS-device
Time frame: 6 months
Support time under MCS
Support time under MCS
Time frame: 6 months
Analysis of New York Heart Association (NYHA) Classification for participants
The New York Heart Association (NYHA) Classification provides a way of classifying the extent of heart failure. It classifies patients in one of four categories based on their limitations during physical activity; the limitations/symptoms are in regards to normal breathing and varying degrees in shortness of breath and or angina pain. Class I is defined as no symptoms and no limitation in ordinary physical activity worsening to Class IV defined as severe limitations.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Kantonsspital Winterthur
Winterthur, Switzerland
RECRUITINGStadtspital Treimli
Zurich, Switzerland
RECRUITINGTime frame: 6 months
Modified rankin scale
Modified rankin scale measures the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological Disability. The scale ranges form 0-6 with 0 defined as no Symptoms and 5 being severe Symptoms and 6 defined as death.
Time frame: 6 months
Number of deceased participants at 6 month after cardiogenic shock
Mortality at 6 months
Time frame: 6 months